Breast Cancer Research and Treatment

, Volume 105, Issue 1, pp 69–80 | Cite as

Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study

  • Jane C. Figueiredo
  • Marguerite Ennis
  • Julia A. Knight
  • John R. McLaughlin
  • Nicky Hood
  • Frances O’Malley
  • Irene L. Andrulis
  • Pamela J. Goodwin
Clinical Epidemiology

Abstract

Purpose

The objective of this study was to examine the association of: (i) diagnosis at age ≤35, (ii) first-degree family history of breast or ovarian cancer (BOC) and (iii) a research based definition of genetic risk, with tumor characteristics, treatment and survival in breast cancer (BC).

Patients and methods

Consenting female participants in the population-based Ontario Familial Breast Cancer Registry diagnosed with primary invasive BC between 1996 and 1998 were followed prospectively until 2005.

Results

Among 967 women, 105 were ≤35 years old at diagnosis and 686 were classified as genetic risk cases, including 349 with a first-degree family history. Individuals diagnosed at age ≤35 were more likely to self-detect tumors, to present with inflammatory BC, to have invasive ductal carcinoma of no special type, high T stage, and tumors with lymphovascular invasion (LVI), high grade and negative estrogen receptors. Younger women were more likely to receive chemotherapy and less likely to receive hormonal therapy. Diagnosis ≤35 years old was associated with significantly reduced distant recurrence free survival, an effect that did not persist after adjustment for tumor and treatment related variables. Poor outcomes were restricted to younger women with hormone responsive BC. Family history was associated with increased rates of mammographic detection of BC, lower tumor stage and less frequent inflammatory BC, but had no association with BC outcomes.

Conclusion

Women diagnosed with BC at age ≤35 have more aggressive tumors; these adverse tumor characteristics, rather than age, lead to poor outcomes. Family history was not associated with survival.

Keywords

Breast cancer Family history Young age Tumor pathology Treatment Survival Population-based Prospective 

Notes

Acknowledgements

The authors would like to acknowledge the important contributions of Gord Glendon, Nayana Weerasooriya and Elaine Maloney of the OFBCR. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the B-CFR, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or B-CFR. This research was supported by the Canadian Breast Cancer Research Agency and the US National Institutes for Health. J.C.F. received a fellowship from the Canadian Breast Cancer Foundation.

References

  1. 1.
    Ruder AM, Moodie PF, Nelson NA, Choi NW (1988) Does family history of breast cancer improve survival among patients with breast cancer? Am J Obstet Gynecol 158:963–968PubMedGoogle Scholar
  2. 2.
    Israeli D, Tartter PI, Brower ST, Mizrachy B, Bratton J (1994) The significance of family history for patients with carcinoma of the breast. J Am Coll Surg 179:29–32PubMedGoogle Scholar
  3. 3.
    Jobsen JJ, Meerwaldt JH, van der Palen J (2000) Family history in breast cancer is not a prognostic factor? Breast 9:83–87PubMedCrossRefGoogle Scholar
  4. 4.
    Russo A, Herd-Smith A, Gestri D, Bianchi S, Vezzosi V, Rosselli Del Turco M, Cardona G (2002) Does family history influence survival in breast cancer cases? Int J Cancer 99:427–430PubMedCrossRefGoogle Scholar
  5. 5.
    Molino A, Giovannini M, Pedersini R, Frisinghelli M, Micciolo R, Mandara M, Pavarana M, Cetto GL (2004) Correlations between family history and cancer characteristics in 2256 breast cancer patients. Br J Cancer 91:96–98PubMedCrossRefGoogle Scholar
  6. 6.
    Verkooijen HM, Chappuis PO, Rapiti E, Vlastos G, Fioretta G, Sarp S, Sappino AP, Schubert H, Bouchardy C (2006) Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study. Br J Cancer 94:231–238PubMedCrossRefGoogle Scholar
  7. 7.
    Fukutomi T, Kobayashi Y, Nanasawa T, Yamamoto H, Tsuda H (1993) A clinicopathological analysis of breast cancer in patients with a family history. Surg Today 23:849–854PubMedCrossRefGoogle Scholar
  8. 8.
    Mohammed SN, Smith P, Hodgson SV, Fentiman IS, Miles DW, Barnes DM, Millis RR, Rubens RD (1998) Family history and survival in premenopausal breast cancer. Br J Cancer 77:2252–2256PubMedGoogle Scholar
  9. 9.
    Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151:703–714PubMedGoogle Scholar
  10. 10.
    Frost MH, Slezak JM, Tran NV, Williams CI, Johnson JL, Woods JE, Petty PM, Donohue JH, Grant CS, Sloan JA, Sellers TA, Hartmann LC (2005) Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol 23:7849–7856PubMedCrossRefGoogle Scholar
  11. 11.
    Thalib L, Wedren S, Granath F, Adami HO, Rydh B, Magnusson C, Hall P (2004) Breast cancer prognosis in relation to family history of breast and ovarian cancer. Br J Cancer 90:1378–1381PubMedCrossRefGoogle Scholar
  12. 12.
    Schouten LJ, Hupperets PS, Jager JJ, Volovics L, Wils JA, Verbeek AL, Blijham GH (1997) Prognostic significance of etiological risk factors in early breast cancer. Breast Cancer Res Treat 43:217–223PubMedCrossRefGoogle Scholar
  13. 13.
    Malone KE, Daling JR, Weiss NS, McKnight B, White E, Voigt LF (1996) Family history and survival of young women with invasive breast carcinoma. Cancer 78:1417–1425PubMedCrossRefGoogle Scholar
  14. 14.
    Colleoni M, Rotmensz N, Robertson C, Orlando L, Viale G, Renne G, Luini A, Veronesi P, Intra M, Orecchia R, Catalano G, Galimberti V, Nole F, Martinelli G, Goldhirsch A (2002) Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 13:273–279PubMedCrossRefGoogle Scholar
  15. 15.
    Shannon C, Smith IE (2003) Breast cancer in adolescents and young women. Eur J Cancer 39:2632–2642PubMedCrossRefGoogle Scholar
  16. 16.
    Walker RA, Lees E, Webb MB, Dearing SJ (1996) Breast carcinomas occurring in young women (<35 years) are different. Br J Cancer 74:1796–1800PubMedGoogle Scholar
  17. 17.
    Winchester DP, Osteen RT, Menck HR (1996) The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer 78:1838–1843PubMedCrossRefGoogle Scholar
  18. 18.
    Kollias J, Elston CW, Ellis IO, Robertson JF, Blamey RW (1997) Early-onset breast cancer—histopathological and prognostic considerations. Br J Cancer 75:1318–1323PubMedGoogle Scholar
  19. 19.
    Chung M, Chang HR, Bland KI, Wanebo HJ (1996) Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 77:97–103PubMedCrossRefGoogle Scholar
  20. 20.
    Adami HO, Malker B, Holmberg L, Persson I, Stone B (1986) The relation between survival and age at diagnosis in breast cancer. N Engl J Med 315:559–563PubMedCrossRefGoogle Scholar
  21. 21.
    Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M (2000) Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 320:474–478PubMedCrossRefGoogle Scholar
  22. 22.
    Han W, Kim SW, Park IA, Kang D, Youn YK, Oh SK, Choe KJ, Noh DY (2004) Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 4:82PubMedCrossRefGoogle Scholar
  23. 23.
    (2001) Consensus conference 2000: adjuvant therapy for breast cancer. National Institutes of Health Consensus Development Conference Statement November 1–3, 2000. Cancer Control 8:55Google Scholar
  24. 24.
    Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ (2001) Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 19:3817–3827PubMedGoogle Scholar
  25. 25.
    Bonnier P, Romain S, Charpin C, Lejeune C, Tubiana N, Martin PM, Piana L (1995) Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer 62:138–144PubMedCrossRefGoogle Scholar
  26. 26.
    Rapiti E, Fioretta G, Verkooijen HM, Vlastos G, Schafer P, Sappino AP, Kurtz J, Neyroud-Caspar I, Bouchardy C (2005) Survival of young and older breast cancer patients in Geneva from 1990 to 2001. Eur J Cancer 41:1446–1452PubMedCrossRefGoogle Scholar
  27. 27.
    Merchant TE, McCormick B, Yahalom J, Borgen P (1996) The influence of older age on breast cancer treatment decisions and outcome. Int J Radiat Oncol Biol Phys 34:565–570PubMedGoogle Scholar
  28. 28.
    Goldhirsch A, Gelber RD, Yothers G, Gray RJ, Green S, Bryant J, Gelber S, Castiglione-Gertsch M, Coates AS (2001) Adjuvant therapy for very young women with breast cancer: need for tailored treatments. J Natl Cancer Inst Monogr 30:44–51Google Scholar
  29. 29.
    Aebi S, Gelber S, Castiglione-Gertsch M, Gelber RD, Collins J, Thurlimann B, Rudenstam CM, Lindtner J, Crivellari D, Cortes-Funes H, Simoncini E, Werner ID, Coates AS, Goldhirsch A (2000) Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet 355:1869–1874PubMedCrossRefGoogle Scholar
  30. 30.
    Andrulis IL, Boyd NF, Sutherland H (1997) New Ontario familial breast cancer registry to facilitate genetic and epidemiologic studies. Can Fam Physician 43:949–950PubMedGoogle Scholar
  31. 31.
    John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, Daly MB, O’Malley FP, Santella RM, Southey MC, Venne VL, Venter DJ, West DW, Whittemore AS, Seminara D (2004) The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 6:R375–R389PubMedCrossRefGoogle Scholar
  32. 32.
    Sutherland HJ, Lacroix J, Knight J, Andrulis IL, Boyd NF (2001) The Cooperative Familial Registry for Breast Cancer Studies: design and first year recruitment rates in Ontario. J Clin Epidemiol 54:93–98PubMedCrossRefGoogle Scholar
  33. 33.
    Knight JA, Sutherland HJ, Glendon G, Boyd NF, Andrulis IL (2002) Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies. Ann Epidemiol 12:27–33PubMedCrossRefGoogle Scholar
  34. 34.
    Holowaty EJ, Marrett LD, Fehringer G (1995) Cancer incidence in Ontario trends and regional variations. The Ontario Cancer Treatment and Research Foundation, TorontoGoogle Scholar
  35. 35.
    Longacre TA, Ennis M, Quenneville LA, Bane AL, Bleiweiss IJ, Carter BA, Catelano E, Hendrickson MR, Hibshoosh H, Layfield LJ, Memeo L, Wu H, O’Malley FP (2006). Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study. Mod Pathol 19:195–207PubMedCrossRefGoogle Scholar
  36. 36.
    Malone KE, Daling JR, Thompson JD, O’Brien CA, Francisco LV, Ostrander EA (1998) BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA 279:922–929PubMedCrossRefGoogle Scholar
  37. 37.
    Haffty BG, Silber A, Matloff E, Chung J, Lannin D (2006) Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women. J Med Genet 43:133–137PubMedCrossRefGoogle Scholar
  38. 38.
    (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717Google Scholar
  39. 39.
    Colleoni M, Gelber S, Goldhirsch A, Aebi S, Castiglione-Gertsch M, Price KN, Coates AS, Gelber RD (2006) Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13–93. J Clin Oncol 24:1332–1341PubMedCrossRefGoogle Scholar
  40. 40.
    Murabito JM, Evans JC, Larson MG, Kreger BE, Splansky GL, Freund KM, Moskowitz MA, Wilson PW (2001) Family breast cancer history and mammography: Framingham Offspring Study. Am J Epidemiol 154:916–923PubMedCrossRefGoogle Scholar
  41. 41.
    Madlensky L, Vierkant RA, Vachon CM, Pankratz VS, Cerhan JR, Vadaparampil ST, Sellers TA (2005) Preventive health behaviors and familial breast cancer. Cancer Epidemiol Biomarkers Prev 14:2340–2345PubMedCrossRefGoogle Scholar
  42. 42.
    Groenendijk RP, Rombouts MC, Ruers TJ, Boetes C, Wobbes T (2002) Breast cancer screening: using familiality for earlier detection. Breast 11:116–119PubMedCrossRefGoogle Scholar
  43. 43.
    Audrain-McGovern J, Hughes C, Patterson F (2003) Effecting behavior change: awareness of family history. Am J Prev Med 24:183–189PubMedCrossRefGoogle Scholar
  44. 44.
    Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 277:997–1003PubMedCrossRefGoogle Scholar
  45. 45.
    Slattery ML, Berry TD, Kerber RA (1993) Is survival among women diagnosed with breast cancer influenced by family history of breast cancer? Epidemiology 4:543–548PubMedCrossRefGoogle Scholar
  46. 46.
    James PA, Doherty R, Harris M, Mukesh BN, Milner A, Young MA, Scott C (2006) Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol 24:707–715PubMedCrossRefGoogle Scholar
  47. 47.
    Mancuso C, Glendon G, Anson-Cartwright L, Shi EJ, Andrulis I, Knight J (2004) Ethnicity, but not cancer family history, is related to response to a population-based mailed questionnaire. Ann Epidemiol 14:36–43PubMedCrossRefGoogle Scholar
  48. 48.
    Olivotto IA, Bajdik CD, Ravdin PM, Speers CH, Coldman AJ, Norris BD, Davis GJ, Chia SK, Gelmon KA (2005) Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 23:2716–2725PubMedCrossRefGoogle Scholar
  49. 49.
    Eerola H, Blomqvist C, Pukkala E, Pyrhonen S, Nevanlinna H (2000) Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 36:1143–1148PubMedCrossRefGoogle Scholar
  50. 50.
    Murff HJ, Byrne D, Syngal S (2004) Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med 27:239–245PubMedGoogle Scholar
  51. 51.
    Murff HJ, Spigel DR, Syngal S (2004) Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 292:1480–1489PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Jane C. Figueiredo
    • 1
    • 2
  • Marguerite Ennis
    • 3
  • Julia A. Knight
    • 1
    • 2
  • John R. McLaughlin
    • 1
    • 2
    • 4
  • Nicky Hood
    • 1
  • Frances O’Malley
    • 5
    • 6
  • Irene L. Andrulis
    • 4
    • 5
    • 6
    • 7
  • Pamela J. Goodwin
    • 2
    • 8
  1. 1.Samuel Lunenfeld Research InstituteMount Sinai HospitalTorontoCanada
  2. 2.Department of Public Health Sciences, Faculty of MedicineUniversity of TorontoTorontoCanada
  3. 3.Applied StatisticianMarkhamCanada
  4. 4.Division of Preventive OncologyCancer Care OntarioTorontoCanada
  5. 5.Department of Pathology and Laboratory MedicineMount Sinai HospitalTorontoCanada
  6. 6.Department of Laboratory Medicine and Pathobiology, Faculty of MedicineUniversity of TorontoTorontoCanada
  7. 7.Samuel Lunenfeld Research InstituteMount Sinai HospitalTorontoCanada
  8. 8.Samuel Lunenfeld Research InstituteMount Sinai HospitalTorontoCanada

Personalised recommendations